Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice
Nonalcoholic fatty liver disease (NAFLD) is increasingly common among patients with type 2 diabetes mellitus (T2DM). The two conditions can act synergistically to produce adverse outcomes. However, the therapeutic options for patients with NAFLD and T2DM are currently limited. Human umbilical cord-d...
Saved in:
Main Authors: | Bing Li, Yu Cheng, Songyan Yu, Li Zang, Yaqi Yin, Jiejie Liu, Lin Zhang, Yiming Mu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/8628027 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
by: Jing Xue, et al.
Published: (2020-01-01) -
Umbilical Cord Mesenchymal Stem Cells Ameliorate Inflammation-Related Tumorigenesis via Modulating Macrophages
by: Yanxia Fu, et al.
Published: (2022-01-01) -
Therapeutic Potential of HGF-Expressing Human Umbilical Cord Mesenchymal Stem Cells in Mice with Acute Liver Failure
by: Yunxia Tang, et al.
Published: (2016-01-01) -
Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications
by: E. Russo, et al.
Published: (2022-01-01) -
Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy
by: Irina Arutyunyan, et al.
Published: (2016-01-01)